MPG.eBooks - Author Search Results

121

CADTH Canadian drug expert committee recommendation: Telotristat ethyl (Xermelo -- Ipsen Biopharmaceuticals Canada Inc) : indication : for the treatment of refractory carcinoid syn...

Published 2019

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

122

CADTH Canadian drug expert committee recommendation: Cysteamine ophthalmic solution (Cystadrops -- recordati rare diseases Canada Inc.) : indication : treatment of corneal cystine...

Published 2019

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

123

CADTH Canadian drug expert committee recommendation: Doravirine (Pifeltro -- Merck Canada Inc.) : indication: in combination with other antiretroviral medicinal products, for the t...

Published 2019

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

124

CADTH Canadian drug expert committee recommendation: Doravirine/Lamivudine/Tenofovir disoproxil fumarate (Delstrigo -- Merck Canada Inc.) : indication: as a complete regimen for th...

Published 2019

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

125

CADTH Canadian drug expert committee recommendation: Lanadelumab (Takhzyro -- shire pharma Canada ULC) : indication: for the routine prevention of attacks of hereditary angioedema...

Published 2019

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

126

Clinical review report: Upadacitinib (Rinvoq) (AbbVie) : indication : for the treatment of adults with moderately to severely active rheumatoid arthritis who have had an inadequate...

Published 2020

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

127

CADTH Canadian drug expert committee recommendation: Upadacitinib (Rinvoq -- abbVie) : indication : for the treatment of adults with moderately to severely active rheumatoid arthri...

Published 2020

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

128

Clinical review report: Upadacitinib (Rinvoq) (AbbVie) : indication : for the treatment of adults with moderately to severely active rheumatoid arthritis who have had an inadequate...

Published 2020

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

129

Clinical review report: Lanadelumab (Takhzyro) (Shire pharma Canada ULC) : indication : for routine prevention of attacks of hereditary angioedema in adolescents and adults

Published 2020

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

130

CADTH Canadian Drug Expert Committee recommendation: Iron isomaltoside 1000 (Monoferric -- pharmacosmos A/S) : indication: for the treatment of iron deficiency anemia in adult pati...

Published 2020

CADTH

“...CADTH Canadian Drug Expert Committee...”

Read Now

131

CADTH Canadian Drug Expert Committee recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: ankylosing spondylitis

Published 2020

CADTH

“...CADTH Canadian Drug Expert Committee...”

132

CADTH Canadian drug expert committee recommendation (final): Certolizumab pegol (Cimzia -- UCB Canada Inc.) : indication : treatment of adult patients with moderate-to severe plaqu...

Published 2019

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

133

CADTH Canadian Drug Expert Committee recommendation: Brolucizumab (Beovu -- Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular...

Published 2020

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

134

CADTH Canadian drug expert committee recommendation: Burosumab (Crysvita -- Kyowa Kirin Limited) : indication : treatment of x-linked hypophosphatemia

Published 2020

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

135

Clinical review report: Brolucizumab (Beovu) (Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular degeneration (AMD)

Published 2020

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

136

CADTH Canadian drug expert committee recommendation: Cabotegravir tablets, cabotegravir extended-release injectable suspension and rilpivirine extended-release injectable suspensio...

Published 2020

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

137

CADTH Canadian drug expert committee recommendation: Ustekinumab (Stelara/Stelara I.V. -- Janssen Inc.) : indication : for the treatment of adult patients with moderately to severe...

Published 2020

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

138

CADTH Canadian Drug Expert Committee final recommendation: Edoxaban : Lixiana-Servier Canada Inc. : indication : venous thromboembolic events

Published 2017

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

139

CADTH Canadian Drug Expert Committee final recommendation: Sapropterin -- resubmission (Kuvan -- BioMarin Pharmaceuticals Canada Inc.) : indication: to reduce blood phenylalanine l...

Published 2016

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

140

CADTH Canadian Drug Expert Committee final recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: moderate to severe plaque psoriasis

Published 2016

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”